News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Shares of Medtronic PLC (MDT) declined by 2.09% to $85.71, ending a five-day winning streak despite a generally strong day for the stock market. The S&P 500 Index rose by 1.66%, and the Dow Jones Industrial Average increased by 1.19%. This performance indicates that …
Sharemaestro market context Price above Trend Line 52 weeks +15.8% · Next-week setup positive 57.9%Medtronic has invested $37 million in CoreMap to accelerate the development of its atrial fibrillation mapping platform. This Series C funding round aims to bring CoreMap's technology, which identifies cardiac sites driving complex arrhythmias for improved ablation treatment, to market faster. The investment highlights …
Medtronic (MDT) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of this medical device company have returned +10.5% over …
Sharemaestro market context Price above Trend Line 52 weeks +15.8% · Next-week setup positive 57.9%CoreMap has secured $37 million in a Series C financing round, led by Medtronic, to advance its electrophysiology mapping system. This funding will accelerate the development of CoreMap's next-generation platform for treating and diagnosing atrial fibrillation (AF) by providing more precise, data-driven insights to …
This article provides an in-depth analysis of ADTRAN Holdings Inc (ADTN), covering its market trends, real-time quotes, and financial performance. It highlights key insights such as stable fundamentals, high growth potential, and a "Buy" rating from analysts with a target price of $18.576. Despite …
Christoph Glingener, Chief Technology Officer of Adtran Holdings, Inc., acquired 9,384 shares in the company due to the vesting of 7,625 Performance Stock Units (PSUs). These PSUs were granted on May 24, 2023, as a bonus award and paid out in shares according to …
Sharemaestro market context Price below Trend Line 52 weeks -8.4%Michelle Quinn, EVP, GC and Secretary of Medtronic plc, reported a tax-withholding transaction where 2,069 Ordinary Shares were withheld upon the vesting of restricted stock units. Following this, she directly holds 20,375 Ordinary Shares, which includes 697 shares acquired through dividend reinvestment. This Form …
Key Points Medtronic underperformed the market over the past five years. But it’s still a compelling turnaround play for value-oriented income investors.10 stocks we like better than Medtronic › Medtronic(NYSE: MDT), one of the world's largest medical device makers, was once a reliable blue …
Sharemaestro market context Price above Trend Line 52 weeks +15.8% · Next-week setup positive 57.9%This article provides a revenue breakdown for Medtronic PLC Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh (MDTC34) based on data from TradingView. It highlights that the "Rest of World" segment contributed the most to revenue, with BRL 97.70 billion last year. The content …
Quantinno Capital Management LP significantly reduced its stake in Medtronic PLC by 28.0% during the first quarter, selling 283,724 shares and now owning 730,567 shares valued at $63,304,000. Other institutional investors also adjusted their positions, and 82.06% of Medtronic's stock is held by institutional …
The California State Teachers Retirement System reduced its holdings in Medtronic (NYSE: MDT) by 2.5% in the first quarter of 2026, selling over 53,000 shares but still retaining a significant stake valued at $176.7 million. Despite this, Medtronic reported strong quarterly earnings and revenue, …
Sharemaestro market context Price above Trend Line 52 weeks +15.8% · Next-week setup positive 57.9%ADTRAN Holdings, Inc. (ADTN.US) is scheduled to release its earnings report after the market closes on August 3. Investors will be awaiting this report to assess the company's financial performance.
Bragar Eagel & Squire, P.C. is investigating ADTRAN Holdings, Inc. after the company announced that its Q2 2026 revenue and operating margin would fall below previous guidance. This shortfall was attributed to a project delay and increased costs, leading to a drop in ADTRAN's …
Bragar Eagel & Squire, P.C., a stockholder rights law firm, is investigating potential claims against ADTRAN Holdings, Inc. (NASDAQ: ADTN) on behalf of its stockholders. The investigation follows ADTRAN's announcement of preliminary Q2 2026 results that fell below guidance due to a project delay …
Medtronic PLC (MDT) shares rose 3.2% today, currently priced at $86.88, significantly below its GF Value™ of $100.02, indicating it is 13.1% undervalued. The company has a GF Score™ of 73/100, suggesting above-average performance, with strong valuation but weak momentum. Insider selling and mixed …
Medtronic (MDT) stock is gaining momentum due to several positive catalysts, including its $650M acquisition of SPR Therapeutics, the deployment of its new Touch Surgery Aide AI platform, and improving regulatory prospects for its renal denervation system. Wall Street analysts maintain a generally bullish …
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Medtronic (MDT) is in focus after a voluntary Class II recall of its DLP One-Piece Pediatric Arterial Cannula, following two complaints about loose foreign material …
Sharemaestro market context Price above Trend Line 52 weeks +15.8% · Next-week setup positive 57.9%Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Medtronic (NYSE:MDT) has completed its US$650m acquisition of SPR Therapeutics. The company formally launched the ViaVerte system at ASPN 2026, expanding its pain therapy portfolio. The deal …
Sharemaestro market context Price above Trend Line 52 weeks +15.8% · Next-week setup positive 57.9%This article provides a risk assessment for Medtronic PLC (MDT), indicating a risk score of 9.76 and ranking 1st in the Healthcare Equipment & Supplies industry. It highlights the company's beta of 0.61, suggesting lower volatility compared to the S&P 500, and includes detailed …
ADTRAN Holdings Inc (ADTN) currently has a weak financial status with a score of 7.65, ranking 16 out of 54 in its industry, despite high operating efficiency. The company reported a 15.48% year-over-year increase in its latest quarterly revenue, reaching $286.09 million, and an …
Analysts have issued a consensus "Moderate Buy" rating for Medtronic PLC (NYSE:MDT), with an average 12-month price target of $98.21, significantly above its current trading price of $83.12. The company recently surpassed quarterly earnings and revenue expectations and increased its quarterly dividend to $0.72 …
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Medtronic stock is coming off a 5 year period where the share price has fallen about 25%, yet current checks suggest the shares sit …
Sharemaestro market context Price above Trend Line 52 weeks +15.8% · Next-week setup positive 57.9%Medtronic (MDT) is currently in focus due to a voluntary Class II recall of its pediatric arterial cannula. Despite a recent recall, the stock is considered undervalued with a fair value of $90.37 per share, compared to its current price of $84.22. The company, …
Kirby McInerney LLP is investigating potential securities fraud claims against ADTRAN Holdings, Inc. (NASDAQ: ADTN). This investigation follows ADTRAN's announcement of preliminary Q2 2026 revenues and operating margins that fell below prior guidance and analyst estimates, leading to a significant drop in its stock …
Medtronic (MDT) recently saw its stock price rise by 1.21% to $84.22, outperforming the S&P 500's daily gain. The company's earnings per share are projected to increase by 10.32% to $1.39 for the upcoming report on September 1, 2026, with revenue expected to reach …
Sharemaestro market context Price above Trend Line 52 weeks +15.8% · Next-week setup positive 57.9%Holzer & Holzer, LLC has launched an investigation into ADTRAN Holdings, Inc. following the company's announcement that its preliminary Q2 2026 revenue and operating margin will not meet prior guidance. The CEO cited a project delay and increased component and freight costs as reasons …
Holzer & Holzer, LLC has launched an investigation into ADTRAN Holdings, Inc. (NASDAQ: ADTN) following the company's preliminary second-quarter 2026 results, which fell below previous guidance. The investigation aims to determine if ADTRAN complied with federal securities laws. The stock price dropped after ADTRAN …
SueWallSt has initiated a shareholder investigation into ADTRAN Holdings (ADTN) following a significant drop in its share price. The investigation focuses on whether ADTRAN adequately disclosed risks related to customer project timing after the company announced preliminary Q2 2026 results that missed prior guidance …
Sharemaestro market context Price below Trend Line 52 weeks -8.4%ADTRAN (ADTN) is scheduled to release its Q2 2026 earnings after market close on Monday, August 3rd, with analysts expecting $0.09 EPS on $290.2 million in revenue. Despite beating previous quarter estimates and showing year-over-year revenue growth, the stock has declined from its 52-week …
Medtronic Plc. (MDT) shows stable neutral readings in shorter time horizons, potentially signaling an easing of a long-term weak bias, according to Stock Traders Daily's AI analysis. The analysis identifies a mid-channel oscillation pattern and an exceptional 34.3:1 risk-reward setup targeting a 10.0% gain …
The article provides a revenue breakdown for ADTRAN Holdings Inc (ADTN), detailing contributions from its key business segments and geographical regions. It shows that Optical networking solutions, Subscriber Solutions & Experience, and Access And Aggregation are the primary business revenue drivers. Regionally, the United …
Medtronic's stock is stabilizing due to strong performance in its diabetes and cardiovascular segments, which are supporting overall earnings. The company has shown mid-single-digit revenue growth and maintains a healthy operating margin, driven by innovation in areas like insulin delivery systems and minimally invasive …
ADTRAN Holdings, Inc. (NASDAQ: ADTN) announced preliminary unaudited Q2 2026 results, with revenue expected to be between $280.0 million and $282.0 million, falling short of previous guidance. The company attributed this miss primarily to a project delay from a single customer and elevated component …
ADTRAN Holdings Inc. (ADTN) is a provider of open, disaggregated networking and communications solutions, with segments including Network Solutions and Services & Support. The company's top executives include Chairman and CEO Mr. Thomas R. Stanton, and its main revenue source in Q1 2026 was …
Paradigm Capital Management Inc. NY significantly reduced its stake in ADTRAN Holdings, Inc. (NASDAQ:ADTN) by 35.1% in the first quarter of 2026, selling 396,709 shares and retaining 733,200 shares valued at $9.2 million. Despite this reduction and some negative sentiment stemming from a legal …
Search by ticker symbol or company name and select a result to open its chart.